Synthetic Studies Using Unsaturated and Active Phosphonium Salts 63
solvent was removed under reduced pressure. The
residue was chromatographed on silica gel by using
n-hexane/EtOAc as the eluents whereupon 17a and
5.22; N, 14.42. C17
69.61; H, 5.15; N, 14.32%); νmax (KBr) cm 2922,
2852 (2 × NH), 1627 ( CH , exocyclic); δ (CDCl
0.97–1.32 (m, 2 × 3H, CH , 18Ab and 18Bb), 2.38
q, JHH = 6.8 Hz, 2H, CH CH , 18Bb), 4.18 (q (ill),
1H, = CHCH , 18Ab), 4.56, 4.68 (2s, br, 2 × 1H,
2NH), 6.64–7.78 (m, 6H, H-furans); δ (CDCl ) 14.1,
, 18Ab and 18Bb) 28.8 (CH ,
H
15
N
3
O
2
(293.33) requires: C,
−
1
2
H
3
)
1
8a (or 17b and 18b) were isolated, respectively.
3
(
2
3
ꢀ
With 15a. 5-Amino-3,4-difur-2 ylfurano[2,3-c]-
3
1
,2-dihydropyridazine (17a) was obtained (8:2, v/v)
c
3
◦
as orange crystals (232 mg, 22%), mp 137–139 C
15.3, 18.2 (2 × CH
3
2
ꢀ
ꢀ
(
from cyclohexane) (found: C, 62.86; H, 3.35; N,
5.78. C14 (267.24) requires: C, 62.92; H, 3.39;
N, 15.72%); νmax (KBr) cm 3054, 2853 (NH
CDCl ) 5.78 (s br, 2H, NH ), 6.68, 6.89 (2d, JHH 3.5
Hz, 4H, 2 × (H , H ), furans), 7.45, 7.69 (2d, JHH
18Bb) 106.3, 106.8, 110.4, 110.7 (2 × (3 -C and 4 -C),
furans), 127.9, 128.3, 129, 130.6, 140.6, 141.6, 143.2,
145.7, 151.2, 152.6, 154.1, 155.8; MS: m/z (EI) (%):
1
H
9
N
3
O
3
−1
2
); δ
H
+
(
3
2
293 (41) [M ], 292 (100), 278 (10), 263 (19), 248
ꢀ
ꢀ
4
3
(35), 232 (16), 220 (45), 149 (24), 67 (33).
The reaction of equimolar amounts of 1 and 15a
(or 15b) under the same condition, again afforded
17a (or 17b) (∼14%) and 18a (or 18b) (∼28%) along
with 1 (∼20%).
ꢀ
5
3
.5 Hz, 2H, 2 × H , furans), 7.74 (s, 1H, 6-CH); δ
c
ꢀ
ꢀ
(CDCl
3
) 106.3, 106.8, 110.3, 110.7 (2 × (3 -C and 4 -
C), furans), 127.2 (9-C), 141.4, 144.6, 145.5 (4-C, 3-C,
ꢀ
and 5-C), 147.2 (6-C), 150.6, 151.6 (2 × 2 -C), 154.5
+
(
(
8-C); MS: m/z (EI) (%): 267 (37) [M ], 252 (100), 239
66), 224 (17), 157 (28), 67 (33).
Reaction of 2-[(Benzylidene)amino]benzonitrile
ꢀ
3
,4-Difur-2 yl-5-methylisopyrrolo[2,3-c]-1,2-di-
(
2) with Vinyl- (3) and Allyltriphenylphos-
hydropyridazine (18a) was obtained (1:1, v/v) as
phonium Bromide (9): Preparation of
Compounds 20 and 21
◦
pale brown crystals (450 mg, 43%), mp 175–177 C
(
C
1
(
from CHCl
3
) (found: C, 67.86; H, 4.11; N, 15.75.
(265.27) requires: C, 67.92; H, 4.18; N,
15
H
11
N
3
O
2
A solution of the appropriate salt 3 or 9 (4.1 mmol)
and 0.8 g (3.88 mmol) Schiff’s base 2 [15] in 30 mL
EtOH was treated with 15 mL, and the mixture was
heated under reflux for 15 (with 3), or 20 h (with 9).
The reaction mixture was worked up as described for
the reaction of 1 + 3, and separated by column chro-
matography, using n-hexane-EtOAc yielding com-
pound 20 (from 3) or 21 (from 9) and unidentified
products.
−1
5.84%); νmax (KBr) cm 2922, 2854 (2 × NH); 1619
CH , exocyclic); NMR (DMSO): 18Aa δ 4.57, 5.25
); 18Ba δ 1.95
), 6.66–7.89 (m, 7H, 6-CH and H-furans);
) 13.7 (CH ), 112.2 ( CH ), 106.4, 106.8,
2
H
(
(
δ
2s, 2 × 1H, 2NH), 4.87 (s, 2H, CH
s, 3H, CH
(CDCl
2
H
3
c
3
3
2
ꢀ
ꢀ
1
10.5, 110.9 (2 × (3 -C and 4 -C), furans), 118.5
(7-C), 122.5, 130.6 (8-C and 9-C), 141.1, 141.8,
ꢀ
1
44.6, 145.2 (2 × 5 -C, furans, 4-C, 3-C), 151.3, 151.6
ꢀ
+
(
2
2 × 2 -C, furans); MS: m/z (EI) (%): 265 (55) [M ],
5-Amino-2-phenylbenzoazepine (20) was ob-
tained (6:4, v/v) as yellow prisms (500 mg, 55%), mp
64 (100), 250 (18), 249 (26), 235 (31), 207 (9), 198
◦
(17), 121 (28), 67 (31).
180–182 C (from acetone) (found: C, 82.11; H, 6.09;
N, 11.9. C16
N, 11.96%); νmax cm 3446–3255 (NH and NH
(CDCl ) 5.49 (s br, 1H, NH), 5.77 (s br, 2H, NH ), 6.23,
6.79 (2d, JHH4.4 Hz, 3-CH and 4-CH), 7.25–8.13 (m,
9H, H-Ph); δ (CDCl ) 111.3 (3-C), 130.78 (4-C), 135.2
H
14
N
2
(234.3) requires: C, 82.02; H, 6.02;
−
1
With 15b. The first fraction (8:2, v/v) af-
forded orange crystals of 5-amino-3,4-difur-2 yl-
2
); δ
H
ꢀ
3
2
6
(
-methylfurano[2,3-c]-1,2-dihydropyridazine (17b)
◦
244 mg, 22%), mp 151–153 C (from MeCN) (found:
C
3
C, 64.11; H, 3.99; N, 14.86. C15
quires: C, 64.05; H, 3.94; N, 14.94%); νmax (KBr) cm
057, 2925 (NH ); δ (CDCl ) 1.32 (s, 3H, CH ) 5.75
s br, 2H, NH
H
11
N
3
O
3
(281.27) re-
(2-C), 121.3, 124.4, 124.9, 126.1, 127.9, 129.6, 131.5
(C C, Ph), 148.2 (5-C); MS: m/z (EI) (%): 234 (18)
[M ], 233 (22), 219 (40), 193 (100), 77 (55).
−
1
+
3
(
(
2
H
3
3
2
), 6.66, 6.87 (2d, JHH = 3.5 Hz, 4H, 2 ×
5-Amino-3-methyl-2-phenylbenzoazepine (21)
ꢀ
ꢀ
4
3
H , H ), furans), 7.46, 7.71 (2d, JHH = 3.5 Hz, 2H,
was obtained (6:4, v/v) as yellow prisms (558 mg,
ꢀ
5
◦
2
1
1
1
(
(
× H -furans); δ
c
(CDCl
3
) 14.2 (CH
3
), 106.4, 106.8,
58%), mp 208–210 C (from EtOH) (found: C, 82.28;
ꢀ
ꢀ
10.2, 110.5 (2 × (3 -C and 4 -C), furans), 127.6 (9-C),
H, 6.42; N, 11.34. C17
82.22; H, 6.49; N, 11.28%); νmax cm 3302, 3061 (NH
and NH ); δ (CDCl ) 1.45 (s, 3H, CH ) 4.41 (s, 1H,
NH), 5.86 (s br, 2H, NH ), 6.67 (s, 1H, 4-CH), 6.94–
7.97 (m, 9H, H-Ph); δ (CDCl ) 14.7 (CH ), 114.6
H
16
N
2
(248.33) requires: C,
−
1
41.6, 143.8, 146.2 (4-C, 3-C, and 5-C), 151.6, 152.2,
ꢀ
54.7, 155.3 (2 × 2 -C, furans, 6-C, 8-C); MS: m/z (EI)
2
H
3
3
+
%): 281 (41) [M ], 266 (41), 253 (33), 252 (100), 224
16), 157 (21), 137 (31), 90 (29), 67 (36).
2
C
3
3
The second fraction (1:1, v/v) yielded orange
crystals of 3,4-difur-2 yl-6H-5-ethyl-7-methyliso-
(4-C), 133.6 (3-C), 136.4 (2-C), 121.6, 122.7, 124.5,
ꢀ
124.9, 126.7, 127.5, 129.8, 131.3 (C C, Ph), 147.2
+
pyrrolo[2,3-c]-1,2-dihydropyridazine (18b) (544 mg,
(5-C); MS: m/z (EI) (%): 248 (14) [M ], 249 (19), 233
◦
4
7%), mp 195–197 C (CHCl
3
) (found: C, 69.66; H,
(52), 218 (27), 193 (100), 77 (62).